Donnerstag, 5. März 2026

The Daily

A curated briefing

Wien heute: Sonnig und zunehmend windig, lebhafter Südostwind (Böen ~40 km/h), mild mit 15°C. Die Sonne schiebt sich wieder ins Rampenlicht — Frühlingsgefühle garantiert. 🌤️

Biotech & Pharma

Moderna Pays Roivant $2.25B to Settle mRNA Patent Lawsuit

Moderna and Roivant Sciences have settled their years-long patent dispute over mRNA vaccine technology. Moderna will pay up to $2.25 billion to resolve claims that its COVID-19 vaccines infringed on Roivant's lipid nanoparticle patents. The settlement includes an upfront payment and milestone-based royalties through 2028. The deal clears a major overhang for Moderna as it pushes into cancer vaccines and respiratory pipeline expansion. Roivant, backed by Sumitomo Pharma, positioned the patents as foundational to modern mRNA delivery systems. Both sides frame the resolution as enabling future collaboration, though Roivant retains enforcement rights against other mRNA developers. The settlement reflects pharma's growing recognition that platform IP battles can stall innovation and drain capital faster than licensing deals.
Source: STAT News, BioPharma Dive

FDA Deputy Commissioner Namandje Bumpus to Retire

FDA's top operating official and Deputy Commissioner for Operations, Namandje Bumpus (who served as interim chief scientist under Butler), will retire after a decades-long career. Her departure adds to concerns about institutional knowledge drain as the agency navigates MAHA-era turbulence. Bumpus was a steadying force through policy shifts and budget crises.
Source: Endpoints News

Craig Crews' PROTAC Empire Expands: Next Startup Wave

Craig Crews, the Yale professor who pioneered PROTACs (and co-founded Arvinas), is ramping up his biotech incubator to launch multiple degrader-focused startups in 2026. With PROTACs maturing into clinical and commercial reality (Arvinas, Nurix, Kymera all advancing), Crews sees untapped modalities: CELMoDs, molecular glues, and tissue-selective degraders. His new ventures aim to tackle CNS, autoimmune, and metabolic targets — arenas where traditional degraders struggled with delivery or toxicity. Investors are backing the "serial PROTAC founder" playbook: platform science from Crews' lab, experienced CEOs, and fast pivots to clinic-ready candidates.
Source: Endpoints Pharma

UCB Boards T-Cell Engager Train With $1.1B Deal

Belgium's UCB Pharma is entering the crowded T-cell engager (TCE) space with a $1.1 billion licensing pact for a preclinical bispecific antibody. The undisclosed asset targets a solid tumor antigen, positioning UCB to compete with AbbVie's Epcoritamab, J&J's Teclistamab, and Roche's glofitamab. UCB's bet reflects the shift from heme-onc (where TCEs shine) to solid tumors — a tougher frontier due to poor T-cell infiltration and immunosuppressive microenvironments. The deal includes upfront payment, milestones, and royalties, with UCB handling global development and commercialization. For UCB, this is a strategic hedge as patents on legacy neurology drugs (Cimzia, Vimpat) expire. The TCE wave is becoming a must-play bet for mid-tier biopharma: it's cheaper than CAR-T, faster to clinic than ADCs, and payers are warming to bispecific outpatient regimens.
Source: Fierce Biotech

Science / Immuno-Oncology

Serial Landmark Analysis of CAR-T in Large B-Cell Lymphoma: Early CR Predicts Long-Term Cure Trend

This multicenter retrospective study of 479 relapsed/refractory LBCL patients treated with CD19 CAR-T (axi-cel, tisa-cel, liso-cel) introduces serial landmark time points (Day 28, 3, 6, 12, 18, and 24 months) to stratify long-term outcomes. Key findings: patients achieving complete response (CR) at Day 28 or Month 3 showed dramatically superior progression-free survival (PFS) compared to partial responders or non-responders. Elevated LDH at infusion and lack of early CR were independently associated with inferior outcomes. Notably, patients maintaining CR beyond 12 months exhibited survival curves approaching a plateau — a tantalizing signal of functional cure in a subset of LBCL patients. The landmark approach addresses the limitation of single-snapshot assessments and provides a dynamic roadmap for risk-adapted post-CAR-T surveillance. The study reinforces that CAR-T is not a binary success/failure therapy: depth and timing of response matter as much as initial CR rate. For clinicians, this offers a framework to identify high-risk patients early and explore consolidation strategies (e.g., bispecifics, checkpoint inhibitors) before relapse. For patients, the 18-24 month plateau offers hope that durable remission may translate to cure.
Source: Transplantation and Cellular Therapy, PubMed 41765136

Lipid Metabolism Drives Dietary Effects on T Cell Ferroptosis and Immunity

This Nature study uncovers how dietary lipid composition regulates T cell susceptibility to ferroptosis — a non-apoptotic cell death driven by iron-dependent lipid peroxidation. In mice, high-fat diets rich in polyunsaturated fatty acids (PUFAs) made CD4+ and CD8+ T cells more prone to ferroptosis, impairing antitumor and antiviral immunity. Conversely, saturated-fat diets or ferroptosis inhibitors (e.g., ferrostatin-1) rescued T cell function and prolonged survival in tumor models. The mechanism: PUFAs integrate into T cell membranes, increasing oxidation substrate and overwhelming antioxidant defenses (GPX4, GSH). The findings position ferroptosis as a diet-modifiable checkpoint in T cell homeostasis — with implications for CAR-T manufacturing (lipid-controlled media to prevent ex vivo ferroptosis?), immunotherapy combinations (ferroptosis inhibitors to boost TIL persistence?), and even dietary interventions to enhance vaccine responses. It's a rare convergence of metabolism, cell death biology, and immunology — and a reminder that what T cells eat matters as much as what genes they express.
Source: Nature, PubMed 41781622

AI & Tech

Claude Hits Record 500K Downloads on Saturday After Pentagon Backlash

Anthropic's Claude mobile app saw over 500,000 downloads on Saturday — its biggest single day on record — following user backlash against OpenAI's Pentagon deal announced Friday night. The surge reflects a growing "vote with your app" movement as consumers react to AI firms' defense contracts. OpenAI had agreed to deploy ChatGPT on classified military networks with ethical guardrails (no mass surveillance, no fully autonomous weapons), filling the void left when Anthropic walked away from similar Pentagon demands earlier in the week. But the optics proved toxic: by Sunday morning, #DeleteChatGPT was trending, and Claude's App Store ranking jumped from #12 to #2 (behind only TikTok). Anthropic, which positioned its Pentagon exit as a principled red line, gained credibility — even as critics note Claude is already used by defense contractors via commercial licenses. The episode underscores AI's new reality: consumer trust is fragile, Pentagon partnerships are PR minefields, and competitors can weaponize ethics messaging as competitive advantage. OpenAI's bet: that guardrails justify DoD collaboration. Anthropic's bet: that staying "clean" attracts users who care. Saturday's download spike suggests Anthropic won Round 1.
Source: The Rundown AI, Exponential View, TechCrunch

Anthropic Exposes Chinese AI Firms' "Distillation Attacks" on Claude

Anthropic revealed that DeepSeek, Moonshot AI, and MiniMax used "distillation" techniques to improperly extract Claude's capabilities and train their own models. Distillation queries a model millions of times, reverse-engineering its responses to replicate behavior without accessing weights. Anthropic argues this crosses ethical and IP lines — and strengthens the case for export controls on AI chips to China. The disclosure comes as Chinese models (especially DeepSeek-V3) close the gap with Western LLMs at a fraction of the cost.
Source: NBC News, Anthropic Blog, Mashable

New Device Jams Phone Microphones to Stop Eavesdropping

A new consumer gadget emits ultrasonic noise that disrupts smartphone microphones, preventing apps from recording ambient conversations. Priced at $89, it's pitched as privacy insurance against AI voice assistants and ad-targeting algorithms that listen 24/7. Early reviews praise the concept but note it also blocks legitimate voice commands (Siri, Alexa). The device taps into growing paranoia that phones "hear" conversations and serve eerily relevant ads minutes later — a phenomenon companies deny but users widely report. It's a Band-Aid for a deeper problem: mic permissions are all-or-nothing, and AI models make eavesdropping more valuable than ever.
Source: Superhuman AI Newsletter

NBA News

Suns Face Brutal Finish: League-Low 9 Home Games, 6 Back-to-Backs Remaining

With playoff seeding tightening in the West, the Phoenix Suns drew the short straw on schedule: they're the only team with a league-low nine home games and a league-high six back-to-backs over the final six weeks. That includes a grueling six-game road trip from March 10-19 featuring two back-to-backs, with rest-disadvantage matchups in Toronto and Minnesota. The Suns (currently 6th seed) are already battling injuries and defensive inconsistency — this schedule could be the difference between home-court advantage and a play-in battle. Meanwhile, Denver and OKC enjoy relatively friendly slates, while the Lakers and Clippers navigate the opposite problem: front-loaded schedules that already burned them. NBA scheduling has always been imperfect, but the impact on playoff positioning is glaring this year. For the Suns, every game is now a must-win — and the margin for error is gone.
Source: NBA.com

Travel

26 Places to Go in Italy in 2026 — Beyond the Venice-Florence-Rome Circuit

Italy Segreta's annual guide makes a bold resolution: retire the basic Venice-Florence-Rome-Amalfi circuit and explore Italy's staggering, under-visited vastness. The 26 picks for 2026 include Matera's ancient cave dwellings, Trieste's Habsburg elegance, Cinque Terre alternatives like Liguria's Tellaro, Umbria's hilltop towns (Spello, Norcia), Sicily's Baroque triangle (Ragusa, Modica, Noto), and Sardinia's hidden coves. For northern Italy: the Dolomites' alpine lakes, Trentino's wine roads, and Verona's quieter charms. Southern highlights: Basilicata's ghost towns, Calabria's wild coast, and Campania's inland volcanic wine country (Irpinia). The guide argues that overtourism has made the "Big 4" less magical — long lines, inflated prices, and crowds that drown out local life. Meanwhile, lesser-known regions offer richer food, lower costs (30-40% cheaper in many cases), and authentic encounters with Italian culture. Whether you're chasing art, nature, food, or solitude, there's a corner of Italy that delivers — without the selfie sticks. The message is clear: 2026 is the year to venture off-circuit and discover the Italy that locals know.
Source: Italy Segreta

What to Do in Venice in March 2026: Ancient New Year, Art Exhibitions, Spring Traditions

March in Venice is a sweet spot: post-Carnival calm, pre-Easter crowds, and mild spring weather. Visititaly.eu highlights Venice's lesser-known March traditions, starting with the city's ancient New Year celebration (March 1 in the Venetian calendar until 1797) — still marked by locals with processions and blessings at San Marco. Art lovers can catch new exhibitions at the Peggy Guggenheim Collection and Palazzo Grassi. Foodies should explore spring produce at Rialto Market (artichokes, asparagus, soft-shell crabs) and try sarde in saor (sweet-sour sardines) at bacari. For active travelers: rowing classes on the lagoon (way cooler than gondolas), walks through quieter sestieri (Cannaregio, Castello), and day trips to Burano and Torcello without summer mobs. Practical tips: book hotels now (prices 20-30% lower than April), pack layers (sunny days, cool evenings), and expect occasional acqua alta (high tides) — but nothing like November. March is Venice at its most livable: still a working city, not just a theme park.
Source: Visititaly.eu

Wien für Kinder

Meerkind, Zirkus und die Abenteuer des kleinen Maulwurf — Wochenend-Highlights

Der "Kind in Wien"-Newsletter empfiehlt diese Woche drei Retro-Klassiker, die Eltern aus den 80ern kennen — und die auch heute noch funktionieren. Meerkind (Dschungel Wien, ab 6 Jahren) erzählt die Geschichte eines Kindes, das zwischen Wasser und Land lebt — poetisch inszeniert mit Musik und Schatten. Zirkus (verschiedene Locations, u.a. Zirkus- und Clownmuseum) lädt zum Staunen ein: Akrobatik, Clownerie, und oft auch Mitmach-Programme für Kids. Die Abenteuer des kleinen Maulwurfs (Kindertheater, ab 4 Jahren) bringt den tschechischen Animations-Klassiker auf die Bühne — minimalistisch, bezaubernd, ohne Worte. Alle drei Events punkten mit analoger Magie statt Bildschirm-Reizüberflutung — perfekt für einen gemütlichen März-Nachmittag. Tickets online buchen, manche Shows sind schnell ausverkauft. Bonus: WIENXTRA bietet parallel gratis Workshops in der Spielebox (Albertgasse) und Stadtbox (Barbara-Prammer-Allee) — ohne Anmeldung, einfach vorbeikommen. Der Frühling in Wien ist für Kinder pures Gold.
Source: FALTER Kind in Wien, WIENXTRA

Frühlingsvaganza Kunstmarkt — 21.-22. März in der Semmelweisklinik

Am Wochenende vom 21. und 22. März findet zum zweiten Mal der Frühlingsvaganza Kunstmarkt in der Semmelweisklinik (9. Bezirk) statt. Das Event verbindet Kunst, Kunsthandwerk, Live-Performances und kulinarische Köstlichkeiten in den historischen Räumen der ehemaligen Klinik. Familien mit Kindern finden kinderfreundliche Stände (Holzspielzeug, Illustrationen, DIY-Workshops) und viel Platz zum Herumstöbern. Der Eintritt ist frei, Essen und Getränke gibt's vor Ort. Perfekt für einen entspannten Frühlings-Ausflug abseits der üblichen Programm-Highlights. Details und Programm auf 1000things.at.
Source: 1000things Magazine

Wien – Kultur & Essen

Wolfgang Puck: "Ich denke nicht ans Aufhören!" — Statt Pension geht's auf Welttournee

Wolfgang Puck dementiert Rückzugsgerüchte mit Nachdruck. Statt in Pension zu gehen, plant der 76-jährige Starkoch gemeinsam mit Sohn Byron eine Welttournee — mit Stopps in Wien, London, Tokio und Los Angeles. Puck, der als österreichischer Auswanderer in den USA zur Küchenlegende wurde (Spago, Cut, CUT by Wolfgang Puck), kehrt immer wieder nach Wien zurück — aus Nostalgie, aber auch weil die Stadt kulinarisch "endlich aufgewacht ist". Im Falstaff-Interview spricht er über seine Anfänge in Kärnten, die Fusion-Küche der 80er, die Pizza-Welle, die er mit kalifornischen Zutaten revolutionierte, und seine Pläne für die nächsten zehn Jahre. "Solange ich Freude daran habe und gesund bleibe, mache ich weiter", sagt Puck. Die Tour startet im Sommer 2026 mit Pop-up-Dinners in ausgewählten Locations. Wien-Termin: Juli, genauer Ort wird noch bekannt gegeben. Puck bleibt Puck: rastlos, hungrig, unsterblich.
Source: Falstaff Österreich

HUHU — Hotpot, Sushi & Saucenstation in Mariahilf

In Mariahilf hat HUHU eröffnet — ein neues Lokal mit Fokus auf individuellen Hotpot, Sushi, chinesische Klassiker und süße Desserts. Das Highlight: eine Saucenstation, an der Gäste ihre Soße selbst zusammenstellen (Sesamöl, Chili, Knoblauch, Koriander, Sojasauce — grenzenlose Kombinationen). Unter der Woche gibt's von Mo-Fr zwischen 12:00 und 14:00 frisch zubereitete Mittagsmenüs (Reis, Nudeln, Ramen, vegane Optionen). Abends trifft kreative Cocktail-Bar auf asiatische Küche. HUHU ist der jüngste Beweis, dass Mariahilf zur Hotspot-Zone für moderne Pan-Asian-Konzepte geworden ist.
Source: Goodnight.at

Bistro Fantasy — Neuer Brunch-Fixpunkt am Margaretenplatz

Der 6. Bezirk hat mit Bistro Fantasy (Margaretenplatz) einen neuen Brunch- und Bistro-Hotspot. Wo früher das iranische Nayeb war, gibt's jetzt moderne europäische Küche mit mediterranen Einflüssen: Eggs Benedict, Avocado-Toast, Pancakes, aber auch Mittagsgerichte wie Pasta, Salate und wechselnde Specials. Das Interieur ist Instagram-freundlich (Marmortische, Pflanzen, helle Farben), der Kaffee kommt von einer Wiener Rösterei. Öffnungszeiten: Di-So ab 9:00 (Montag Ruhetag). Reservierung empfohlen, besonders fürs Wochenende. Bistro Fantasy reiht sich ein in die neue Generation an Wiener Brunch-Cafés, die französisches Flair mit lokalem Charme verbinden.
Source: Gastro.news